Literature DB >> 35004959

The role of B cells in metabolic (dysfunction)-associated fatty liver disease.

Ziyan Pan1, Wah-Kheong Chan2, Mohammed Eslam1.   

Abstract

Entities:  

Year:  2021        PMID： 35004959      PMCID： PMC8683912          DOI： 10.21037/hbsn-21-404

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  12 in total

1.  Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation.

Authors:  Fei Chen; Saeed Esmaili; Geraint B Rogers; Elisabetta Bugianesi; Salvatore Petta; Giulio Marchesini; Ali Bayoumi; Mayada Metwally; Mahmoud Karimi Azardaryany; Sally Coulter; Jocelyn M Choo; Ramy Younes; Chiara Rosso; Christopher Liddle; Leon A Adams; Antonio Craxì; Jacob George; Mohammed Eslam
Journal:  Hepatology       Date:  2020-01-24       Impact factor: 17.425

2.  The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.

Authors:  Mohammed Eslam; Shiv K Sarin; Vincent Wai-Sun Wong; Jian-Gao Fan; Takumi Kawaguchi; Sang Hoon Ahn; Ming-Hua Zheng; Gamal Shiha; Yusuf Yilmaz; Rino Gani; Shahinul Alam; Yock Young Dan; Jia-Horng Kao; Saeed Hamid; Ian Homer Cua; Wah-Kheong Chan; Diana Payawal; Soek-Siam Tan; Tawesak Tanwandee; Leon A Adams; Manoj Kumar; Masao Omata; Jacob George
Journal:  Hepatol Int       Date:  2020-10-01       Impact factor: 6.047

Review 3.  Genetic Insights for Drug Development in NAFLD.

Authors:  Mohammed Eslam; Jacob George
Journal:  Trends Pharmacol Sci       Date:  2019-05-31       Impact factor: 14.819

4.  B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease.

Authors:  Teruki Miyake; Masanori Abe; Yoshio Tokumoto; Masashi Hirooka; Shinya Furukawa; Teru Kumagi; Maho Hamada; Keitarou Kawasaki; Fujimasa Tada; Teruhisa Ueda; Yoichi Hiasa; Bunzo Matsuura; Morikazu Onji
Journal:  Hepatol Int       Date:  2012-02-09       Impact factor: 6.047

5.  Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study.

Authors:  Salvatore Petta; Mohammed Eslam; Luca Valenti; Elisabetta Bugianesi; Marco Barbara; Calogero Cammà; Marianna Porzio; Chiara Rosso; Silvia Fargion; Jacob George; Antonio Craxì
Journal:  Liver Int       Date:  2017-03-13       Impact factor: 5.828

Review 6.  Immune regulatory function of B cells.

Authors:  Claudia Mauri; Anneleen Bosma
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

Review 7.  Adaptive immunity: an emerging player in the progression of NAFLD.

Authors:  Salvatore Sutti; Emanuele Albano
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-10-11       Impact factor: 46.802

Review 8.  Macrophages in metabolic associated fatty liver disease.

Authors:  Jawaher Alharthi; Olivier Latchoumanin; Jacob George; Mohammed Eslam
Journal:  World J Gastroenterol       Date:  2020-04-28       Impact factor: 5.742

9.  Microbiota-Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling.

Authors:  Fanta Barrow; Saad Khan; Gavin Fredrickson; Haiguang Wang; Katrina Dietsche; Preethy Parthiban; Sacha Robert; Thomas Kaiser; Shawn Winer; Adam Herman; Oyedele Adeyi; Marialena Mouzaki; Alexander Khoruts; Kristin A Hogquist; Christopher Staley; Daniel A Winer; Xavier S Revelo
Journal:  Hepatology       Date:  2021-08       Impact factor: 17.425

Review 10.  The Emerging Role of B Cells in the Pathogenesis of NAFLD.

Authors:  Fanta Barrow; Saad Khan; Haiguang Wang; Xavier S Revelo
Journal:  Hepatology       Date:  2021-06-18       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.